Community stack
Gut Healing Stack
BPC-157 + KPV
This pairing targets gut-specific goals distinct from the other four stacks here: leaky gut, IBS/IBD-type symptoms, post-antibiotic gut dysfunction and general intestinal-lining repair, rather than tendon, skin or GH-axis goals.
Community stack - not clinically tested
No clinical trial has tested this exact combination. The rationale below is built from each compound's individual research, and the dosing is community-derived. None of these compounds is FDA-approved for this use.
What is in it
Why people run it
Sources converge on a repair-plus-anti-inflammatory logic: BPC-157 is credited with regenerating gut lining and repairing ulcers and intestinal damage through angiogenesis and growth-factor activity - Western Health Screening adds tight-junction repair specifically - while KPV, a tripeptide fragment of alpha-MSH, is credited with calming gut inflammation by blocking NF-kB signaling and cytokine production 'without suppressing the immune system' (Elevation Wellness). Western Health Screening frames it directly: rebuilding the barrier without controlling inflammation, or vice versa, leaves recovery incomplete. This traces to each compound's individually documented mechanism - BPC-157's angiogenic and mucosal-protective actions, KPV's NF-kB-linked anti-inflammatory activity - not to a study of the pair together.
Community dosing
communityReported ranges vary by source. My Peptide Match describes BPC-157 250-500 mcg orally once or twice daily plus KPV 200-500 mcg orally or subcutaneously daily, both over 4-8 weeks. Western Health Screening instead describes a two-phase protocol: an acute phase (weeks 1-8) of BPC-157 500 mcg twice daily with KPV 2 mg twice daily, stepping down to a maintenance phase (weeks 9-12) of BPC-157 250 mcg once daily with KPV 1 mg once daily.
Work out your draw in the calculatorThe honest caveat
No source claims a clinical trial of BPC-157 plus KPV together. My Peptide Match states outright there is 'a lack of human studies on their combined use' and that the protocol's efficacy is 'extrapolated from individual peptide data rather than direct clinical evidence.' Western Health Screening rates its own evidence base as 'Level 4 - Case series / Animal studies.' This pairing also does not have one settled name the way Wolverine/GLOW/KLOW do - Elevation Wellness calls it the 'GutTide Stack' and Western Health Screening calls it the 'Gut Barrier Protocol'; 'Gut Healing Stack' is used here as the neutral, most broadly recognizable description of the same BPC-157 + KPV pairing, not a single universally-used trade name.
Sources
- [1]BPC-157 and KPV StackNames the combination the 'GutTide Stack'; states goals of restoring gut lining integrity, calming chronic inflammation and immune modulation for IBS, IBD, food sensitivities and post-antibiotic gut dysfunction; describes BPC-157's regenerative GI effects and KPV as anti-inflammatory 'without suppressing the immune system.'
- [2]Gut Healing Peptide Protocol: BPC-157, KPV and More for GIDescribes BPC-157 as enhancing angiogenesis and protecting gastric mucosa and KPV as modulating the NF-kB pathway to reduce cytokine production; gives dosing (BPC-157 250-500 mcg oral 1-2x/day, KPV 200-500 mcg oral/subcutaneous daily, both 4-8 weeks); states 'a lack of human studies on their combined use,' with efficacy 'extrapolated from individual peptide data.'
- [3]The Gut Barrier Protocol: Synergizing BPC-157 and KPV for Complete GI RepairNames the combination the 'Gut Barrier Protocol'; describes BPC-157 rebuilding mucosal structure via VEGF and tight-junction repair while KPV blocks NF-kB signaling; gives a two-phase acute/maintenance dosing schedule; rates its own evidence strength as 'Level 4 - Case series / Animal studies,' indicating no human clinical trial data exists for the pair.
Other stacks